About

Dr. Karan Gupta is a pioneering head and neck surgeon whose research focuses on the role of transoral robotic surgery (TORS) in treating HPV-negative oropharyngeal and supraglottic cancers. His major contributions lie in systematically evaluating oncological outcomes following both de-intensification and intensification of treatment using TORS, particularly for advanced-stage disease. Through prospective trials at a tertiary cancer care center in New Delhi, India, Dr. Gupta has provided critical evidence that TORS can be safely and effectively applied in HPV-negative patients, a population often considered higher risk. His most cited work, a 2017 prospective trial on stage I and II HPV-negative oropharyngeal cancers, has garnered 35 citations, underscoring its impact on clinical decision-making. He has also explored the feasibility of robotic hemithyroidectomy via transaxillary and retroauricular approaches, expanding the scope of minimally invasive surgery. Dr. Gupta’s research is instrumental in shaping surgical protocols for HPV-negative head and neck cancers, offering patients improved functional outcomes without compromising oncological safety. His work continues to influence the global conversation on robotic surgery in oncology.

Research Focus

Key Achievements

3
H-Index
5
Papers
78
Total Citations
16
Avg Citations/Paper
🏆 Most Cited Paper
Oncological outcome following de-intensification of treatment for stage I and II HPV negative oropharyngeal cancers with transoral robotic surgery (TORS): A prospective trial
35 citations · 2017
📈 Most Prolific Year: 2017 (2 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Rajiv Gandhi Cancer Institute and Research Centre, Medanta The Medicity, BLK Super Speciality Hospital, Fortis Memorial Research Institute

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago